252
Views
9
CrossRef citations to date
0
Altmetric
Reviews

The use of cryoablation in treating liver tumors

&

References

  • Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127(12), 2893–2917 (2010).
  • Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 362(9399), 11–11 (2003).
  • Kim WR, Gores GJ, Benson JT, Therneau TM, Melton LJ III. Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology 129(2), 486–493 (2005).
  • McCarter MD, Fong Y. Metastatic liver tumors. Sem. Surg. Oncol. 19(2), 177–188 (2000).
  • Bala MM, Riemsma RP, Wolff R, Kleijnen J. Cryotherapy for liver metastases. Cochrane Library (2011).
  • Cha C, DeMatteo RP, Blumgart LH. Surgery and ablative therapy for hepatocellular carcinoma. J. Clin. Gastroenterol. 35(5 Suppl. 2), S130–S137 (2002).
  • Hananel N, Garzon J, Gordon PH. Hepatic resection for colorectal liver metastases. Am. Surg. 61(5), 444–447 (1995).
  • Cha CC, Lee FTF, Rikkers LFL, Niederhuber JEJ, Nguyen BTB, Mahvi DMD. Rationale for the combination of cryoablation with surgical resection of hepatic tumors. J. Gastrointest. Surg. 5(2), 206–213 (2001).
  • McCarter MD, Fong Y. Metastatic liver tumors. Sem. Surg. Oncol. 19(2), 177–188 (2000).
  • Ahmed MM, Brace CLC, Lee FTF, Goldberg SNS. Principles of and advances in percutaneous ablation. Radiology 258(2), 351–369 (2011).
  • Hinshaw JL, Lee FT Jr. Cryoablation for liver cancer. Tech. Vasc. Intervent. Radiol. 10(1), 47–57 (2007).
  • Erinjeri JP, Clark TWI. Cryoablation: mechanism of action and devices. J. Vasc. Intervent. Radiol. 21(8 Suppl.), S187–S191 (2010).
  • Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 235(1), 289–298 (2005).
  • Tatli S, Morrison PR, Tuncali K, Silverman SG. Interventional MRI for oncologic applications. Tech. Vascu. Intervent. Radiol. 10(2), 159–170 (2007).
  • Silverman SGS, Tuncali KK, van Sonnenberg EE et al. Renal tumors: MR imaging-guided percutaneous cryotherapy--initial experience in 23 patients. Radiology 236(2), 716–724 (2005).
  • Mala TT, Edwin BB, Samset EE et al. Magnetic-resonance-guided percutaneous cryoablation of hepatic tumours. Eur. J. Surg. 167(8), 610–617 (2001).
  • Lee SM, Won JY, Lee DY et al. Percutaneous cryoablation of small hepatocellular carcinomas using a 17-gauge ultrathin probe. Clin. Radiol. 66(8), 752–759 (2011).
  • Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations. Radiology 237(1), 366–370 (2005).
  • Morrison PR, Silverman SG, Tuncali K, Tatli S. MRI-guided cryotherapy. J. Magn. Reson. Imaging 27(2), 410–420 (2008).
  • Weber, Lee, Chinn, Warner, Chosy, Mahvi. Perivascular and intralesional tissue necrosis after hepatic cryoablation: results in a porcine model. Surgery 122(4), 6–6 (1997).
  • Gage AAA, Baust JJ. Mechanisms of tissue injury in cryosurgery. Cryobiology 37(3), 16–16 (1998).
  • Rubinsky B. Cryosurgery. Ann. Rev. Biomed. Eng. 2(1), 157–187 (2000).
  • Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 60(2 Suppl. 1), 40–49 (2002).
  • Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int. 95(9), 1187–1191 (2005).
  • Mala T. Cryoablation of liver tumours – a review of mechanisms, techniques and clinical outcome. Minim. Invasive Ther. Allied Technol. 15(1), 9–17 (2006).
  • Hoffmann NE, Coad JE, Huot CS, Swanlund DJ, Bischof JC. Investigation of the mechanism and the effect of cryoimmunology in the copenhagen rat. Cryobiology 42(1), 59–68 (2001).
  • Yang W-L, Addona T, Nair DG, Qi L, Ravikumar TS. Apoptosis induced by cryo-injury in human colorectal cancer cells is associated with mitochondrial dysfunction. Int. J. Cancer 103(3), 360–369 (2002).
  • Mascarenhas BA, Ravikumar TS. Experimental basis for hepatic cryotherapy. Sem. Surg. Oncol. 14(2), 110–115 (2012).
  • Maccini M, Sehrt D, Pompeo A, Chicoli FA, Molina WR, Kim FJ. Biophysiologic considerations in cryoablation: a practical mechanistic molecular review. Int. Braz. J. Urol. 37(6), 693–696 (2012).
  • Popken F, Seifert JK, Engelmann R, Dutkowski P, Nassir F, Junginger T. Comparison of iceball diameter and temperature distribution achieved with 3-mm accuprobe cryoprobes in porcine and human liver tissue and human colorectal liver metastases in vitro. Cryobiology 40(4), 302–310 (2000).
  • Seifert JK, Gerharz CD, Mattes F et al. A pig model of hepatic cryotherapy. In vivo temperature distribution during freezing and histopathological changes. Cryobiology 47(3), 214–226 (2003).
  • Permpongkosol S, Nicol TL, Link RE et al. Differences in ablation size in porcine kidney, liver, and lung after cryoablation using the same ablation protocol. AJR Am. J. Roentgenol. 188(4), 1028–1032 (2007).
  • Theodorescu D. Cancer cryotherapy: evolution and biology. Rev. Urol. 6(Suppl. 4), S9–S19 (2004).
  • Silverman SGS, Tuncali KK, Adams DFD et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 217(3), 657–664 (2000).
  • Gage AA, Fazekas G, Riley EE. Freezing injury to large blood vessels in dogs. With comments on the effect of experimental freezing of bile ducts. Surgery 61(5), 748–754 (1967).
  • Eggstein S, Neeff H, Szarzynski M et al. Hepatic cryotherapy involving the vena cava. Eur. Surg. Res. 35(2), 67–74 (2003).
  • Tuncali K, Morrison PR, Tatli S, Silverman SG. MRI-guided percutaneous cryoablation of renal tumors: use of external manual displacement of adjacent bowel loops. Eur. J. Radiol. 59(2), 198–202 (2006).
  • Goldberg SN, Charboneau JW, Dodd GD et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 228(2), 335–345 (2003).
  • Silverman SG, Tuncali K, Morrison PR. MR Imaging-guided percutaneous tumor ablation1. Acad. Radiol. 12(9), 1100–1109 (2005).
  • Adam RR, Majno PP, Castaing DD, Giovenardi RR, Bismuth HH. Treatment of irresectable liver tumours by percutaneous cryosurgery. Br. J. Surg. 85(11), 1493–1494 (1998).
  • Schuder G, Pistorius G, Schneider G, Feifel G. Preliminary experience with percutaneous cryotherapy of liver tumours. Br. J. Surg. 85(9), 1210–1211 (1998).
  • Adam RR, Hagopian EJE, Linhares MM et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch. Surg. 137(12), 1332–1340 (2002).
  • Qian G-JG, Chen HH, Wu M-CM. Percutaneous cryoablation after chemoembolization of liver carcinoma: report of 34 cases. HBPD INT 2(4), 520–524 (2003).
  • Xu K-C, Niu L-Z, He W-B, Guo Z-Q, Hu Y-Z, Zuo J-S. Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. WJG 9(12), 2686–2689 (2003).
  • Mala T, Edwin B, Mathisen Ø et al. Cryoablation of colorectal liver metastases: minimally invasive tumour control. Scand. J. Gastroenterol. 39(6), 571–578 (2004).
  • Yang Y, Wang C, Lu Y et al. Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma. J. Hepatobiliary Pancreat. Sci. 19(6), 674–684 (2011).
  • Weber SMS, Lee FTF, Warner TFT, Chosy SGS, Mahvi DMD. Hepatic cryoablation: US monitoring of extent of necrosis in normal pig liver. Radiology 207(1), 73–77 (1998).
  • Lee FT, Chosy SG, Littrup PJ, Warner TF, Kuhlman JE, Mahvi DM. CT-monitored percutaneous cryoablation in a pig liver model: pilot study. Radiology 211(3), 687–692 (1999).
  • Huang AA, McCall JMJ, Weston MDM et al. Phase I study of percutaneous cryotherapy for colorectal liver metastasis. Br. J. Surg. 89(3), 303–310 (2002).
  • Park BK, Morrison PR, Tatli S et al. Estimated effective dose of CT-guided percutaneous cryoablation of liver tumors. Eur. J. Radiol. 1–5 (2011).
  • Tatli S, Acar M, Tuncali K, Morrison PR, Silverman S. Percutaneous cryoablation techniques and clinical applications. Diagn. Interv. Radiol. 16(1), 90–95 (2010).
  • Tatli S, Acar M, Tuncali K, Sadow CA, Morrison PR, Silverman SG. MRI assessment of percutaneous ablation of liver tumors: value of subtraction images. J. Magn. Reson. Imaging. 37(2), 407–413 (2012).
  • Shyn PB, Oliva MR, Shah SH, Tatli S, Catalano PJ, Silverman SG. MRI contrast enhancement of malignant liver tumours following successful cryoablation. Eur. Radiol. 22(2), 398–403 (2011).
  • Langenhoff BS. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J. Clin. Oncol. 20(22), 4453–4458 (2002).
  • Solomon SB, Silverman SG. Imaging in interventional oncology. Radiology 257(3), 624–640 (2010).
  • Ryan ER, Sofocleous CT, Schöder H et al. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology 268(1), 288–295 (2013).
  • Wilson SRS, Greenbaum LDL, Goldberg BBB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR Am. J. Roentgenol. 193(1), 55–60 (2009).
  • Guibal A, Bertin C, Egels S, Savier E, Grenier PA, Lucidarme O. Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time. Eur. Radiol. 23(5), 1392–1400 (2012).
  • Mazzaferro V, Regalia E, Doci R. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334(11), 693–700 (1996).
  • Karanicolas PJ, Jarnagin WR, Gonen M et al. Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg. 148(7), 597–601 (2013).
  • Fairchild A, Tatli S, Dunn RM, Shyn PB, Silverman SG. Can we freeze the gallbladder safely? Percutaneous cryoablation of hepatic masses adjacent to the gallbladder. J. Vasc. Intervent. Radiol. 1–1 (2013).
  • Silverstein JC, Staren E, Velasco J. Thermal bile duct protection during liver cryoablation. 64, 163–164 (1997).
  • Silverman SGS, Sun MRMM, Tuncali KK et al. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am. J. Roentgenol. 183(3), 707–712 (2004).
  • Orlacchio A, Bazzocchi G, Pastorelli D et al. Percutaneous cryoablation of small hepatocellular carcinoma with us guidance and ct monitoring: initial experience. Cardiovasc Intervent. Radiol. 31(3), 587–594 (2008).
  • Mu F, Niu L, Li H et al. Percutaneous comprehensive cryoablation for metastatic hepatocellular cancer. Cryobiology 1–5 (2012).
  • Dohi MM, Harada JJ, Mogami TT, Fukuda KK, Toyama YY, Kashiwagi HH. MR-guided percutaneous cryotherapy of malignant liver tumor under horizontal-magnetic open system: initial experience. J. Hepato-Biliary-Pancreatic Surg. 10(5), 360–365 (2003).
  • Wu B, Xiao Y-Y, Zhang X, Zhang A-L, Li H-J, Gao D-F. Magnetic resonance imaging-guided percutaneous cryoablation of hepatocellular carcinoma in special regions. HBPD INT. 9(4), 384–392 (2010).
  • Li Z, Zhang C, Lou C et al. Comparison of percutaneous cryosurgery and surgical resection for the treatment of small hepatocellular carcinoma. Oncol Lett. 6(1), 239–245 (2013).
  • Nair RT, Silverman SG, Tuncali K, Obuchowski NA, van Sonnenberg E, Shankar S. Biochemical and Hematologic Alterations Following Percutaneous Cryoablation of Liver Tumors: experience in 48 Procedures. Radiology 248(1), 303–311 (2008).
  • Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J. Surg. 23(2), 109–104 (1999).
  • Goodie DB, Horton MD, Morris RW, Nagy LS, Morris DL. Anaesthetic experience with cryotherapy for treatment of hepatic malignancy. Anaesth. Intensive Care 20(4), 491–496 (1992).
  • Shafir M, Shapiro R, Sung M, Warner R, Sicular A, Klipfel A. Cryoablation of unresectable malignant liver tumors. Am. J. Surg. 171(1), 27–31 (1996).
  • Bilchik AJ, Wood TF, Allegra D et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch. Surg. 135(6), 657–662, discussion 662–664 (2000).
  • Shankar S, Tuncali K, vanSonnenberg E, Seifter JL, Silverman SG. Myoglobinemia after CT-guided radiofrequency ablation of a hepatic metastasis. AJR Am. J. Roentgenol. 178(2), 359–361 (2002).
  • Choi DD, Lim HKH, Kim MJM et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am. J. Roentgenol. 184(6), 1860–1867 (2005).
  • Sainani NI, Aghayev A, Shyn PB, Silverman SG, Tatli S. Imaging spectrum following percutaneous cryoablation of hepatic tumors. ARRS Abstract Book 1–2 (2013).
  • Tuna I, Tatli S, Tuncali K, Silverman SG. Frequency and clinical impact of venous thrombosis following percutaneous cryoablation of hepatic tumors. Presented at: Radiological Society of North America 98th Scientific Assembly and Annual Meeting. Chicago, IL, USA, 25–30 November 2012.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.